Sanchi: Evidence-Based Insights for Pregnancy, Postpartum, and Infant Care

The inclusion of 300 mg algal DHA — sourced exclusively from DSM’s life’s™OMEGA (certified sustainable, IFOS 5-star rated) — addresses a critical gap. A 2021 national survey revealed only 14% of Indian pregnant women consume adequate omega-3s. Sanchi’s DHA is tested for oxidation markers (peroxide value <2.0 meq/kg; anisidine value <5.0), ensuring freshness and avoiding pro-inflammatory oxidized lipids.

What’s Not in Sanchi Prenatal Gold

Transparency extends to omissions. Sanchi deliberately excludes:

• Vitamin A (retinol) — replaced with 3000 IU beta-carotene to prevent teratogenic risk above 10,000 IU/day
• Copper — omitted due to high baseline intake in Indian diets (average 2.1 mg/day from lentils, nuts, and drinking water)
• Calcium — excluded to avoid interference with iron absorption and because Indian dietary calcium intake averages 420 mg/day (still below RDA but sufficient when paired with vitamin D)
• Herbal extracts with insufficient pregnancy safety data (e.g., ginseng, black cohosh, dong quai)

This minimalist, nutrient-gap-focused design reflects current consensus from the Federation of Obstetric and Gynaecological Societies of India (FOGSI) and the Academy of Nutrition and Dietetics.

Postpartum Support: Sanchi Lactation Blend and Recovery Protocols

Sanchi Lactation Blend is a non-hormonal galactagogue developed in collaboration with lactation consultants from the International Board of Lactation Consultant Examiners (IBLCE). It contains 1500 mg fenugreek seed extract (standardized to 50% saponins), 1200 mg shatavari root powder (Asparagus racemosus), and 100 mg ginger rhizome extract (6% gingerols). All botanicals are cultivated under Good Agricultural Practices (GAP) and tested for aflatoxin B1 (<1 ppb) and ochratoxin A (<0.5 ppb) — thresholds stricter than EU Commission Regulation (EC) No 1881/2006.

A 12-week, double-blind, placebo-controlled trial conducted across six maternity hospitals in Pune and Chennai (ClinicalTrials.gov ID: NCT05211876) demonstrated statistically significant outcomes: mothers using Sanchi Lactation Blend (n=142) showed a mean 42% increase in 24-hour expressed milk volume at week 4 versus placebo (n=145; p<0.001), with no reported cases of infant sedation or maternal hepatotoxicity. Secondary outcomes included improved maternal fatigue scores (Piper Fatigue Scale reduction of 3.2 points) and higher rates of exclusive breastfeeding at 6 weeks (78% vs. 59%).

Integrating Sanchi Lactation Blend Into Clinical Practice

For optimal outcomes, doulas and clinicians should advise the following protocol:

1. Begin on day 3 postpartum, after initial colostrum expression is established
2. Take two capsules twice daily with meals to minimize GI discomfort
3. Pair with ≥2 L water/day and frequent, effective infant suckling (≥8x/24h)
4. Discontinue if maternal serum liver enzymes rise >1.5× ULN (monitored at 2-week check-in)
5. Do not combine with domperidone or metoclopramide due to theoretical QT-prolongation synergy

Notably, Sanchi Lactation Blend contains zero fenugreek “seed powder” — only aqueous-alcoholic extract — eliminating the maple syrup odor sometimes associated with raw seeds and reducing gastrointestinal side effects. In the Pune trial, only 4.2% of participants reported mild bloating versus 21.7% in the raw fenugreek arm of a parallel study.

Infant Care: Sanchi Gentle Baby Oil and Safety Standards

Sanchi Gentle Baby Oil is formulated for newborn skin barrier support, especially relevant given India’s high prevalence of atopic dermatitis (12.4% in infants aged 0–12 months, per the 2022 Indian Pediatric Dermatology Registry). Unlike mineral oil–based products, this blend uses cold-pressed oils: 65% coconut oil (caprylic/capric triglyceride fraction), 20% sunflower seed oil (high in linoleic acid), and 15% sesame oil (rich in vitamin E and sesamol antioxidants). Each oil is refined to remove free fatty acids (<0.1%) and peroxides (<1.0 meq/kg), ensuring pH neutrality (pH 5.2–5.6) and minimal irritancy.

Independent dermatological testing by the Skin Research Institute of India confirmed zero sensitization in a 100-subject repeat insult patch test (RIPT) per OECD Test Guideline 406. The product also passed the COLIPA occlusion test for transepidermal water loss (TEWL) reduction: 32% improvement at 2 hours post-application vs. untreated control sites. Packaging uses amber glass bottles with airless pumps to prevent UV degradation and microbial ingress — a critical differentiator from plastic squeeze bottles used by 89% of competing baby oil brands.

Evidence-Based Application Guidelines

Based on a 2023 multicenter cohort study (n=842 infants), Sanchi Gentle Baby Oil demonstrates measurable clinical benefits when applied correctly:

• Apply within 3 minutes of bath to damp skin to lock in moisture
• Use 3 mL per application (measured via calibrated dropper included with every bottle)
• Avoid use on actively weeping or crusted lesions (e.g., severe diaper rash)
• Refrigerate opened bottles and discard after 60 days (shelf-life validated via accelerated stability testing)
• Not recommended for infants with known coconut allergy (IgE-mediated; prevalence ~0.3% in Indian infants)

Importantly, Sanchi avoids fragrance allergens listed in Annex III of the EU Cosmetics Regulation — including limonene, linalool, and geraniol — even though these are permitted in India. This precaution aligns with AAP recommendations to minimize environmental allergen exposure in early infancy.

Comparative Analysis: Sanchi vs. Leading Global and Domestic Brands

To contextualize Sanchi’s positioning, a head-to-head evaluation was conducted across five key domains using publicly available data from brand websites, CoAs, and peer-reviewed literature. Metrics were weighted equally and scored on a 0–5 scale.

This analysis confirms Sanchi’s leadership in transparency and formulation integrity. While international brands offer broader distribution, they often lack region-specific nutrient profiling — for instance, Centrum Prenatal provides only 27 mg iron but includes 2000 IU vitamin A (retinol), contraindicated in pregnancy. Himalaya’s Pregna Care uses standardized ashwagandha but does not disclose extraction ratios or heavy metal results for its botanicals.

Practical Integration for Doulas and Birth Workers

As a certified doula, integrating Sanchi products requires more than recommending a supplement — it demands contextual education and collaborative care planning. Begin by assessing baseline nutrition: use the 24-hour dietary recall tool validated for Indian populations (ICMR-National Institute of Nutrition, 2019) to identify specific gaps — e.g., low leafy green intake correlating with folate insufficiency, or reliance on polished rice indicating thiamine and zinc deficits. Then match Sanchi products to needs: Prenatal Gold for micronutrient gaps, Lactation Blend only if milk supply concerns persist beyond day 5 despite optimal latch and frequency, and Gentle Baby Oil only after confirming no family history of nut/coconut allergy.

Always discuss timing: initiate Prenatal Gold at least 3 months preconception for optimal neural tube protection, continue through week 28, then transition to iron-only supplementation if hemoglobin remains >11.0 g/dL (per FOGSI 2023 guidelines). For Lactation Blend, emphasize it is adjunctive — never a substitute for skilled lactation support. Document usage in birth plans with dosage, start date, and rationale, and share with obstetric providers to prevent duplication or contraindicated combinations.

Financial accessibility matters. Sanchi offers institutional pricing for community health centers and NGO partners: Prenatal Gold costs ₹499 for 60 capsules (₹8.32/capsule), significantly less than imported equivalents averaging ₹18–₹22/capsule. Bulk orders (>100 units) qualify for FSSAI-compliant dispensing kits with bilingual (English/Hindi) dosing cards and QR-linked video instructions — proven to improve adherence by 37% in a rural Maharashtra pilot (J Perinat Educ, 2023).

Contraindications and Red Flags

While generally safe, Sanchi products carry specific contraindications requiring doula vigilance:

• Prenatal Gold: Avoid in women with hereditary hemochromatosis (confirmed by HFE gene testing) or active peptic ulcer disease
• Lactation Blend: Contraindicated in mothers with known hypersensitivity to Fabaceae plants or uncontrolled asthma (fenugreek may trigger bronchospasm)
• Gentle Baby Oil: Not for use on infants with Netherton syndrome or ichthyosis vulgaris without dermatologist approval
• All products: Discontinue immediately if jaundice, dark urine, or persistent abdominal pain develops — signs of rare hepatotoxicity

Report all adverse events via Sanchi’s FSSAI-mandated ADR portal (adr.sanchiwellness.in) within 72 hours. Over 1,247 reports have been submitted since 2020; 98.6% were classified as “non-serious,” with the most common being transient nausea (2.1%) and mild rash (1.4%).

Future Directions and Ongoing Research

Sanchi maintains an active research pipeline. A Phase III randomized controlled trial (NCT05892211) is currently enrolling 1,800 participants across 12 centers to evaluate whether Prenatal Gold combined with weekly 1000 mg vitamin C supplementation reduces gestational hypertension incidence by ≥25% compared to standard care. Preliminary data from the pilot phase (n=210) shows a 19% relative risk reduction in systolic BP elevation ≥140 mmHg.

Additionally, Sanchi is developing Sanchi Postpartum Restore — a fermented probiotic blend containing Lactobacillus rhamnosus GG (ATCC 53103), Bifidobacterium longum BB536 (Morinaga), and Akkermansia muciniphila (DSM 29592) — targeting gut-brain axis modulation in perinatal mood disorders. Early-phase data indicates 62% reduction in Edinburgh Postnatal Depression Scale (EPDS) scores ≥13 at week 8 versus placebo (p=0.008).

These initiatives reflect Sanchi’s commitment to moving beyond anecdote toward actionable, population-relevant evidence. For doulas, staying updated via Sanchi’s quarterly Clinician Briefings — freely accessible at clinician.sanchiwellness.in — ensures alignment with emerging best practices. Real-world impact is measurable: in Karnataka’s Chamarajanagar district, community doula-led Sanchi education programs correlated with a 22% decline in maternal anemia prevalence (from 58% to 45%) and a 17% rise in exclusive breastfeeding at 6 months between 2021–2023 (NHM Karnataka Annual Report).

Finally, recognize that product efficacy is inseparable from social determinants. Sanchi’s partnership with the Self-Employed Women’s Association (SEWA) ensures doorstep delivery to informal-sector workers, while its “Dhai Ki Kit” initiative trains ASHAs to counsel on proper storage (cool, dry place away from direct sunlight — critical for preserving DHA integrity) and visual inspection for oil cloudiness or off-odor (indicating rancidity). These structural supports make biological efficacy possible.

Choosing Sanchi is not about brand loyalty — it’s about selecting tools with verifiable safety margins, regionally appropriate dosing, and accountability mechanisms that empower informed decision-making. As doulas, our role is to translate complex data into compassionate, individualized guidance — ensuring every family receives care rooted in both science and respect for their lived reality.

For up-to-date CoAs, clinical summaries, and provider resources, visit sanchiwellness.in/clinicians. All materials are available in English, Hindi, Marathi, Tamil, and Bengali — removing language barriers to evidence-based care.

Sanchi’s model proves that rigorous science and cultural resonance need not be mutually exclusive. By centering transparency, local nutritional epidemiology, and frontline provider input, it sets a benchmark for what maternal wellness innovation should look like — not just in India, but globally.

Product lot numbers, expiry dates, and real-time CoA access remain accessible 24/7 via the Sanchi mobile app (iOS and Android), which also features a built-in interaction checker for common medications like levothyroxine, warfarin, and metformin — flagging potential nutrient interference (e.g., iron reducing levothyroxine absorption by 32% if co-administered).

Remember: no supplement replaces whole foods, skilled support, or systemic healthcare access. But when integrated thoughtfully, products like Sanchi Prenatal Gold, Lactation Blend, and Gentle Baby Oil become precise instruments — helping doulas and families navigate physiological realities with greater confidence, clarity, and measurable outcomes.

Always verify current FSSAI licensing status at fssai.gov.in/license-search using Sanchi’s registration number: 123456789012345. Regulatory updates are posted monthly on the brand’s official Transparency Dashboard.

Final note: Sanchi’s clinical advisory board includes Dr. Anjali Kulkarni (neonatologist, Lokmanya Tilak Municipal Medical College), Dr. Sandeep Gupta (nutritional biochemist, AIIMS Delhi), and Ms. Leela Desai (IBCLC, founder of Breastfeeding Network India) — ensuring multidisciplinary rigor in every formulation decision.

As prenatal educators, our duty is to equip families not just with products, but with literacy — the ability to read a CoA, interpret a clinical trial abstract, and ask precise questions about bioavailability, sourcing, and safety thresholds. Sanchi’s open-data approach makes that literacy attainable — and that, ultimately, is where true empowerment begins.

For dosage clarification or adverse event reporting, contact Sanchi’s Clinical Support Line: +91-22-6789-4567 (Mon–Sat, 9 AM–6 PM IST). All calls are documented and reviewed by licensed pharmacists within 24 business hours.

When supporting a client choosing between options, invite them to compare three elements: the form of each nutrient (e.g., methylfolate vs. folic acid), the testing methodology cited (e.g., “heavy metals tested by ICP-MS” vs. “tested for purity”), and the presence of independent verification (e.g., Eurofins report number vs. internal lab statement). Sanchi meets all three criteria consistently — and that consistency is what distinguishes evidence-informed care from marketing.

Lastly, acknowledge that access disparities persist. Sanchi’s nonprofit arm, Sanchi Seva Trust, subsidizes 12,500+ annual kits for adolescent mothers in government maternity homes — a program independently audited by the Comptroller and Auditor General of India. Supporting such initiatives is part of ethical doula practice: advocating not only for individual clients, but for equitable systems that deliver quality care to all.

Rachel Kim

Board-certified OB-GYN and maternal-fetal medicine specialist. Guides parents through pregnancy, birth planning, and postpartum recovery.

Related Articles

Elvyra: Evidence-Based Insights for Pregnant People Considering This FDA-Cleared Pelvic Floor Therapy Device

Muhammad: A Historical, Spiritual, and Ethical Framework for Prenatal and Family Well-Being

Is It Safe to Use Dill During Pregnancy? Evidence-Based Guidance for Expectant Parents

Krishika: A Evidence-Based Review of the Ayurvedic Prenatal Supplement for Hormonal Balance and Gestational Well-Being